MedCap AB (publ) (STO:MCAP)
Sweden
· Delayed Price · Currency is SEK 392.00
-2.50 (-0.63%)
Feb 21, 2025, 5:29 PM CET
MedCap AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 1,807 | 1,598 | 1,124 | 926.3 | 825.8 | Upgrade
|
| Other Revenue | - | 1.6 | 0.2 | - | 2.2 | Upgrade
|
| Revenue | 1,807 | 1,600 | 1,124 | 926.3 | 828 | Upgrade
|
| Revenue Growth (YoY) | 12.94% | 42.32% | 21.34% | 11.87% | 9.32% | Upgrade
|
| Cost of Revenue | 749.6 | 661 | 446.8 | 357.7 | 350.2 | Upgrade
|
| Gross Profit | 1,057 | 938.7 | 677.2 | 568.6 | 477.8 | Upgrade
|
| Selling, General & Admin | 698.5 | 601.1 | 443.5 | 384.6 | 329.2 | Upgrade
|
| Other Operating Expenses | 6.4 | 7.9 | 3.3 | 4.7 | 7.5 | Upgrade
|
| Operating Expenses | 820.3 | 713 | 528.1 | 464.8 | 404.8 | Upgrade
|
| Operating Income | 236.8 | 225.7 | 149.1 | 103.8 | 73 | Upgrade
|
| Interest Expense | -15.7 | -15.6 | -16.4 | -9.4 | -9.1 | Upgrade
|
| Interest & Investment Income | 8.3 | 7 | 2.3 | 0.4 | 1.1 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 1.3 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 14.7 | 2.8 | 1.7 | 8.5 | Upgrade
|
| Other Non Operating Income (Expenses) | 35.5 | 0.1 | 0.1 | - | 3.2 | Upgrade
|
| EBT Excluding Unusual Items | 264.9 | 231.9 | 137.9 | 97.8 | 76.7 | Upgrade
|
| Merger & Restructuring Charges | - | -10.4 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 20 | 4 | - | Upgrade
|
| Asset Writedown | - | - | -6.5 | - | - | Upgrade
|
| Other Unusual Items | -3.3 | - | 0.6 | 15.1 | 4.8 | Upgrade
|
| Pretax Income | 261.6 | 222.3 | 152 | 117 | 81.5 | Upgrade
|
| Income Tax Expense | 52.3 | 49.8 | 34 | 18.9 | 17 | Upgrade
|
| Earnings From Continuing Operations | 209.3 | 172.5 | 118 | 98.1 | 64.5 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -1.7 | Upgrade
|
| Net Income to Company | 209.3 | 172.5 | 118 | 98.1 | 62.8 | Upgrade
|
| Minority Interest in Earnings | -1.9 | -0.3 | -0.4 | -1.6 | -1.9 | Upgrade
|
| Net Income | 207.4 | 172.2 | 117.6 | 96.5 | 60.9 | Upgrade
|
| Net Income to Common | 207.4 | 172.2 | 117.6 | 96.5 | 60.9 | Upgrade
|
| Net Income Growth | 20.44% | 46.43% | 21.87% | 58.46% | 13.41% | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 14 | Upgrade
|
| Shares Change (YoY) | -0.21% | 0.33% | 0.04% | 3.10% | 6.72% | Upgrade
|
| EPS (Basic) | 14.00 | 11.63 | 7.94 | 6.52 | 4.24 | Upgrade
|
| EPS (Diluted) | 14.00 | 11.60 | 7.90 | 6.50 | 4.24 | Upgrade
|
| EPS Growth | 20.66% | 46.84% | 21.54% | 53.18% | 6.39% | Upgrade
|
| Free Cash Flow | 318.3 | 205.9 | 59.2 | 71 | 103.9 | Upgrade
|
| Free Cash Flow Per Share | 21.47 | 13.86 | 4.00 | 4.80 | 7.24 | Upgrade
|
| Gross Margin | 58.51% | 58.68% | 60.25% | 61.38% | 57.71% | Upgrade
|
| Operating Margin | 13.11% | 14.11% | 13.27% | 11.21% | 8.82% | Upgrade
|
| Profit Margin | 11.48% | 10.76% | 10.46% | 10.42% | 7.36% | Upgrade
|
| Free Cash Flow Margin | 17.62% | 12.87% | 5.27% | 7.66% | 12.55% | Upgrade
|
| EBITDA | 352.2 | 277.8 | 188.6 | 141.1 | 104.3 | Upgrade
|
| EBITDA Margin | 19.49% | 17.37% | 16.78% | 15.23% | 12.60% | Upgrade
|
| D&A For EBITDA | 115.4 | 52.1 | 39.5 | 37.3 | 31.3 | Upgrade
|
| EBIT | 236.8 | 225.7 | 149.1 | 103.8 | 73 | Upgrade
|
| EBIT Margin | 13.11% | 14.11% | 13.27% | 11.21% | 8.82% | Upgrade
|
| Effective Tax Rate | 19.99% | 22.40% | 22.37% | 16.15% | 20.86% | Upgrade
|
| Revenue as Reported | 1,842 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.